Drug Type Fusion protein |
Synonyms MBNL1-antibody conjugate (4s3) |
Target |
Mechanism MBNL1 stimulators(Muscleblind like protein 1 stimulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myotonic Dystrophy | Phase 1 | US | - |